Cargando…

What is the future of treatment de-escalation for HPV-positive oropharyngeal cancer? A review of ongoing clinical trials

BACKGROUND: Human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) has increased in incidence in recent decades. With higher cure rates in younger populations, long-term survivors may live with acute- and long-term toxicity, leading to increased interest in de-escalation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mensour, Emma A., Alam, Shintha, Mawani, Seliya, Bahig, Houda, Lang, Pencilla, Nichols, Anthony, Palma, David A., Jasper, Katie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816564/ https://www.ncbi.nlm.nih.gov/pubmed/36620554 http://dx.doi.org/10.3389/fonc.2022.1067321

Ejemplares similares

Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial
por: Nichols, Anthony C., et al.
Publicado: (2020)

The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies
por: Wierzbicka, Małgorzata, et al.
Publicado: (2015)

Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?
por: Mirghani, Haitham, et al.
Publicado: (2017)

The immune response in HPV(+) oropharyngeal cancer
por: King, Emma V, et al.
Publicado: (2014)

Sensitive HPV detection in oropharyngeal cancers
por: Winder, David M, et al.
Publicado: (2009)

Does HPV type affect outcome in oropharyngeal cancer?
por: Nichols, Anthony C, et al.
Publicado: (2013)

Impact of HPV in Oropharyngeal Cancer
por: Marklund, Linda, et al.
Publicado: (2011)

Targeted Therapy as a Potential De-Escalation Strategy in Locally Advanced HPV-Associated Oropharyngeal Cancer: A Literature Review
por: Chitsike, Lennox, et al.
Publicado: (2021)

Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification
por: Zeng, Peter Y.F., et al.
Publicado: (2022)

Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial
por: Jones, David A., et al.
Publicado: (2020)

Japan’s Ongoing Crisis on HPV Vaccination
por: Sekine, Masayuki, et al.
Publicado: (2020)

Immunotherapy in HPV-Related Oropharyngeal Cancers
por: Roof, Logan, et al.
Publicado: (2023)

HPV-mediated oropharyngeal carcinogenesis: An overview
por: Patil†, Shankargouda
Publicado: (2022)

HPV+ Oropharyngeal Cancer in Waldenström Macroglobulinemia
por: Raslan, Shahm, et al.
Publicado: (2023)

Deep Learning Based HPV Status Prediction for Oropharyngeal Cancer Patients
por: Lang, Daniel M., et al.
Publicado: (2021)

Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer
por: Wurlitzer, Marcus, et al.
Publicado: (2020)

Oral/oropharyngeal “selfies” in gay and bisexual men: a pilot study exploring oropharyngeal screening for HPV-related possible malignancies
por: Ross, Michael W., et al.
Publicado: (2023)

Advances in the Management of HPV-Related Oropharyngeal Cancer
por: De Felice, F., et al.
Publicado: (2019)

Comparing cisplatin-Chemoradiotherapy to Cetuximab-radiotherapy in HPV(+) “low-risk” locally advanced oropharyngeal squamous cell carcinoma: lessons from De-escalate study
por: Economopoulou, Panagiota, et al.
Publicado: (2019)

Evaluation of p16(INK4a) expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation
por: Wagner, Steffen, et al.
Publicado: (2020)

De-escalated radiation for human papillomavirus virus-related oropharyngeal cancer: evolving paradigms and future strategies
por: Chen, Allen M.
Publicado: (2023)

Targeting HPV in gynaecological cancers – Current status, ongoing challenges and future directions
por: Crusz, Shanthini M, et al.
Publicado: (2020)

Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects
por: Embring, Anna, et al.
Publicado: (2023)

Correction: Evaluation of p16(INK4a) expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation
por: Wagner, Steffen, et al.
Publicado: (2021)

Ongoing inadequacy of quadrivalent HPV vaccine safety studies
por: Little, Deirdre T, et al.
Publicado: (2020)

Fluid Biomarkers in HPV and Non-HPV Related Oropharyngeal Carcinomas: From Diagnosis and Monitoring to Prognostication—A Systematic Review
por: Lee, Shaun C., et al.
Publicado: (2022)

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
por: Mehanna, Hisham, et al.
Publicado: (2019)

HPV in oropharyngeal cancer: the basics to know in clinical practice
por: Elrefaey, S., et al.
Publicado: (2014)

Current perspectives on recurrent HPV-mediated oropharyngeal cancer
por: Guo, Theresa, et al.
Publicado: (2022)

Surgical clinical trials for HPV-positive oropharyngeal carcinoma
por: Lin, Chen, et al.
Publicado: (2022)

Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years
por: Haeggblom, Linnea, et al.
Publicado: (2017)

Differences in T-cell infiltrates and survival between HPV+ and HPV- oropharyngeal squamous cell carcinoma
por: Matlung, Sanne Evelien, et al.
Publicado: (2016)

Dynamics and Determinants of HPV Infection: The Michigan HPV and Oropharyngeal Cancer (M-HOC) Study
por: Eisenberg, Marisa C, et al.
Publicado: (2018)

The Effect of Prophylactic HPV Vaccines on Oral and Oropharyngeal HPV Infection—A Systematic Review
por: Nielsen, Kristoffer Juul, et al.
Publicado: (2021)

Oral health in HPV-positive and HPV-negative patients with oropharyngeal squamous cell carcinoma
por: Kanzow, Philipp, et al.
Publicado: (2023)

Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future Perspectives
por: Krasniqi, Eriseld, et al.
Publicado: (2021)

Adaptive dose escalated radiotherapy in oropharyngeal cancers: a treatment planning feasibility study
por: Grocutt, Laura, et al.
Publicado: (2022)

Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost
por: Embring, Anna, et al.
Publicado: (2023)

Modern treatment outcomes for early T-stage oropharyngeal cancer treated with intensity-modulated radiation therapy at a tertiary care institution
por: Di Gravio, Eric J., et al.
Publicado: (2020)

Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer
por: Chera, Bhishamjit S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bitu3jkhvgd4q4t32821c9b1f3